Importance of Lymph Node Involvement in Pancreatic Neuroendocrine Tumors: Impact on Survival and Implications for Surgical Resection

被引:72
作者
Curran, Thomas [1 ]
Pockaj, Barbara A. [2 ]
Gray, Richard J. [2 ]
Halfdanarson, Thorvardur R. [3 ]
Wasif, Nabil [2 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA
[2] Mayo Clin Arizona, Sect Surg Oncol, Dept Surg, Phoenix, AZ 85054 USA
[3] Mayo Clin Arizona, Dept Med Oncol, Phoenix, AZ USA
关键词
Pancreatic neuroendocrine tumor; Lymph node; Survival surgery; PROGNOSTIC-FACTORS; ENDOCRINE TUMORS; SYSTEM;
D O I
10.1007/s11605-014-2624-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Conflicting data exist on predictors of nodal metastases and their impact on survival in patients with pancreatic neuroendocrine tumors (PNETs). We aim to identify factors associated with lymph node involvement and evaluate the effect of nodal metastases on survival. Methods All patients undergoing surgery for PNETs in the Surveillance, Epidemiology, and End Results (SEER) tumor registry from 1988 to 2010 were included. Predictors of lymph node involvement and disease-specific survival (DSS) were evaluated using logistic regression and Cox regression, respectively. Results Patients (1,915) underwent surgery for a PNET (62 % nonfunctional). Nodal positivity was associated with increasing tumor size (p<0.001) and grade (p<0.001). Unadjusted DSS at 5 years was 81 % for N0, 74 % for Nx, and 69 % for N1, respectively, (p<0.001). After adjustment for tumor size and grade, DSS was significantly decreased in N1 patients (HR 1.57; 95 % CI 1.23-1.95). For patients who had at least one node examined and had low-grade PNETs <1 cm, no nodal metastases were found. Conclusions High tumor grade and increasing size predict nodal metastases in patients with PNETs. N1 status is independently associated with decreased DSS. Low-grade tumors <1 cm may be observed or enucleated.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 24 条
  • [1] [Anonymous], 2010, WHO CLASSIFICATION T
  • [2] Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours
    Bettini, R.
    Boninsegna, L.
    Mantovani, W.
    Capelli, P.
    Bassi, C.
    Pederzoli, P.
    Delle Fave, G. F.
    Panzuto, F.
    Scarpa, A.
    Falconi, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (05) : 903 - 908
  • [3] Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors
    Bilimoria, Karl Y.
    Bentrem, David J.
    Merkow, Ryan P.
    Tomlinson, James S.
    Stewart, Andrew K.
    Ko, Clifford Y.
    Talamonti, Mark S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (04) : 558 - 563
  • [4] Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
    Cetinkaya, Raziye Boyar
    Vatn, Morten
    Aabakken, Lars
    Bergestuen, Deidi S.
    Thiis-Evensen, Espen
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2014, 49 (06) : 734 - 741
  • [5] Biochemistry of neuroendocrine tumours
    de Herder, Wouter W.
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) : 33 - 41
  • [6] Clinicopathological Characteristics and Prognosis-Related Factors of Resectable Pancreatic Neuroendocrine Tumors A Retrospective Study of 104 Cases in a Single Chinese Center
    Han, Xu
    Xu, Xuefeng
    Jin, Dayong
    Wang, Dansong
    Ji, Yuan
    Lou, Wenhui
    [J]. PANCREAS, 2014, 43 (04) : 526 - 531
  • [7] Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors
    Hasegawa, Toshiyuki
    Yamao, Kenji
    Hijioka, Susumu
    Bhatia, Vikram
    Mizuno, Nobumasa
    Hara, Kazuo
    Imaoka, Hiroshi
    Niwa, Yasumasa
    Tajika, Masahiro
    Kondo, Shinya
    Tanaka, Tutomu
    Shimizu, Yasuhiro
    Kinoshita, Taira
    Kohsaki, Takuhiro
    Nishimori, Isao
    Iwasaki, Shinji
    Saibara, Toshiji
    Hosoda, Waki
    Yatabe, Yasushi
    [J]. ENDOSCOPY, 2014, 46 (01) : 32 - 38
  • [8] Regional Lymphadenectomy Is Indicated in the Surgical Treatment of Pancreatic Neuroendocrine Tumors (PNETs)
    Hashim, Yassar M.
    Trinkaus, Kathryn M.
    Linehan, David C.
    Strasberg, Steven S.
    Fields, Ryan C.
    Cao, Dengfeng
    Hawkins, William G.
    [J]. ANNALS OF SURGERY, 2014, 259 (02) : 197 - 203
  • [9] Implications of Incidentally Discovered, Nonfunctioning Pancreatic Endocrine Tumors Short-term and Long-term Patient Outcomes
    Haynes, Alex B.
    Deshpande, Vikram
    Ingkakul, Thun
    Vagefi, Parsia A.
    Szymonifka, Jackie
    Thayer, Sarah P.
    Ferrone, Cristina R.
    Wargo, Jennifer A.
    Warshaw, Andrew L.
    Fernandez-del Castillo, Carlos
    [J]. ARCHIVES OF SURGERY, 2011, 146 (05) : 534 - 538
  • [10] Surgery and Staging of Pancreatic Neuroendocrine Tumors: A 14-Year Experience
    Ito, Hiromichi
    Abramson, Michael
    Ito, Kaori
    Swanson, Edward
    Cho, Nancy
    Ruan, Daniel T.
    Swanson, Richard S.
    Whang, Edward E.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (05) : 891 - 898